Debbie Rigby rounds up the latest in research news Embedded on-site aged care pharmacists in Australia Qualitative semistructured interviews explored the roles of early adopters of Australia’s embedded on-site pharmacist …

Debbie Rigby rounds up the latest in research news Heart failure with comorbid dementia One-fifth of persons over age 65 with HF also have comorbid dementia. Co-occurring HF and dementia …

Debbie Rigby rounds up the latest in research news Over-the-counter use of short-acting beta-2 agonists The availability of SABA as an over-the-counter (OTC) medication has contributed to overuse, leading to …

Debbie Rigby rounds up the latest in research news Efficacy of Probiotics in Irritable Bowel Syndrome A Systematic Review and Meta-analysis has concluded that some combinations of probiotics or strains …

Debbie Rigby takes a look at the latest in research news Older people, medication usage and long-term care pharmacists A retrospective cohort study of 1366 people aged 65 years and …

Debbie Rigby rounds up the latest in research news Deprescribing Tool for Older PeoPle with Limited-life Expectancy (De-TOPPLE) Older people with limited life expectancy (LLE) have a higher risk of …

Debbie Rigby takes a look at the latest in research news Restless legs syndrome Restless legs syndrome (RLS) is a common sensorimotor disorder causing significant distress. Brain iron deficiency, dopaminergic …

Debbie Rigby takes a look at the latest research news Efficacy of Ferric carboxymaltose in heart failure with iron deficiency Analysis of data from 3 trials with a total of …

Debbie Rigby takes a look at the latest research news Balancing risks and benefits of cannabis use This umbrella review of meta-analyses of randomised controlled trials and observational studies concludes …

Debbie Rigby takes a look at the latest research news Evidence supporting the choice of a new cardiovascular risk equation for Australia The Australian CVD risk assessment and management guideline, …

Debbie Rigby takes a look at the latest in research news Weight loss with subcutaneous semaglutide versus other glucagon-like peptide 1 receptor agonists in type 2 diabetes Glucagon-like peptide 1 …